Ozempic maker Novo Nordisk (NVO) announced mixed results today for a phase 2 trial of an experimental weight loss pill that works differently than its already-popular weight loss drug Wegovy.Read more…
Read More
Ozempic maker Novo Nordisk (NVO) announced mixed results today for a phase 2 trial of an experimental weight loss pill that works differently than its already-popular weight loss drug Wegovy.Read more…
Read More
Enter your details below to save your shopping cart for later. And, who knows, maybe we will even send you a sweet discount code :)
Allow notifications to get real-time updates about your shopping cart and who knows, you may even receive a sweet discount code 😊